205 related articles for article (PubMed ID: 29297384)
1. Upregulation of NETO2 gene in colorectal cancer.
Fedorova MS; Snezhkina AV; Pudova EA; Abramov IS; Lipatova AV; Kharitonov SL; Sadritdinova AF; Nyushko KM; Klimina KM; Belyakov MM; Slavnova EN; Melnikova NV; Chernichenko MA; Sidorov DV; Kiseleva MV; Kaprin AD; Alekseev BY; Dmitriev AA; Kudryavtseva AV
BMC Genet; 2017 Dec; 18(Suppl 1):117. PubMed ID: 29297384
[TBL] [Abstract][Full Text] [Related]
2. HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer.
Pudova EA; Kudryavtseva AV; Fedorova MS; Zaretsky AR; Shcherbo DS; Lukyanova EN; Popov AY; Sadritdinova AF; Abramov IS; Kharitonov SL; Krasnov GS; Klimina KM; Koroban NV; Volchenko NN; Nyushko KM; Melnikova NV; Chernichenko MA; Sidorov DV; Alekseev BY; Kiseleva MV; Kaprin AD; Dmitriev AA; Snezhkina AV
BMC Genomics; 2018 Feb; 19(Suppl 3):113. PubMed ID: 29504907
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin and tolloid-like 2 regulates the progression of osteosarcoma.
Wang X; Bian Z; Hou C; Li M; Jiang W; Zhu L
Gene; 2021 Feb; 768():145292. PubMed ID: 33157203
[TBL] [Abstract][Full Text] [Related]
5. Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer.
He J; Huang H; Du Y; Peng D; Zhou Y; Li Y; Wang H; Zhou Y; Nie Y
Cell Oncol (Dordr); 2020 Jun; 43(3):409-420. PubMed ID: 32166582
[TBL] [Abstract][Full Text] [Related]
6. NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients.
Liu JY; Jiang L; He T; Liu JJ; Fan JY; Xu XH; Tang B; Shi Y; Zhao YL; Qian F; Wang Y; Cui YH; Yu PW
Cell Death Dis; 2019 Feb; 10(3):162. PubMed ID: 30770791
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Sun J; Ding C; Yang Z; Liu T; Zhang X; Zhao C; Wang J
J Transl Med; 2016 Feb; 14():42. PubMed ID: 26856330
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
9. NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway.
Xu JC; Chen TY; Liao LT; Chen T; Li QL; Xu JX; Hu JW; Zhou PH; Zhang YQ
Int J Biol Sci; 2021; 17(1):259-270. PubMed ID: 33390848
[TBL] [Abstract][Full Text] [Related]
10. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
11. TYMSOS-miR-101-3p-NETO2 axis promotes osteosarcoma progression.
Zhang Z; Wang J; Zhang X; Ran B; Wen J; Zhang H
Mol Cell Probes; 2023 Feb; 67():101887. PubMed ID: 36509232
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
13. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
14. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.
Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D
Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986
[TBL] [Abstract][Full Text] [Related]
15. Role of SSH1 in colorectal cancer prognosis and tumor progression.
Song X; Xie D; Xia X; Tan F; Pei Q; Li Y; Zhou Z; Zhou Y; Li C; Wang K; Pei H
J Gastroenterol Hepatol; 2020 Jul; 35(7):1180-1188. PubMed ID: 32020663
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Li H; Rokavec M; Jiang L; Horst D; Hermeking H
Gastroenterology; 2017 Aug; 153(2):505-520. PubMed ID: 28435028
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
18.
Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
[TBL] [Abstract][Full Text] [Related]
19. Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer.
Mo S; Zhang L; Dai W; Han L; Wang R; Xiang W; Wang Z; Li Q; Yu J; Yuan J; Cai S; Cai G
Cell Death Dis; 2020 Feb; 11(2):155. PubMed ID: 32111819
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA SNHG17 promotes lung adenocarcinoma progression by targeting the microRNA-193a-5p/NETO2 axis.
Zhang Z; Yan Y; Zhang B; Ma Y; Chen C; Wang C
Oncol Lett; 2021 Dec; 22(6):818. PubMed ID: 34671432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
